Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Olfaktoru traucējumu anketa× | NOSE× | |
|---|---|---|
| Nozare | Otolaringoloģija | Otolaringoloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 2003 | 2004 |
| Autors≠ | Thomas Hummel and colleagues; adapted by Benninger et al. | Mark G. Stewart, David L. Witsell, Thomas L. Smith, and colleagues |
| Tips | Self-report | Self-report |
| Pirmavots≠ | Hummel, T., Sekinger, B., Wolf, S. R., Pauli, E., & Kobal, G. (1997). 'Sniffin' Sticks': Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chemical Senses, 22(1), 39-52. DOI ↗ | Stewart, M. G., Witsell, D. L., Smith, T. L., Weaver, E. M., Yueh, B., & Hannley, M. T. (2004). Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) Scale. Otolaryngology - Head and Neck Surgery, 130(2), 157-163. DOI ↗ |
| Citi nosaukumi≠ | QOD, Olfactory Disorders Questionnaire | NOSE |
| Saistītās | 1 | 1 |
| Kopsavilkums≠ | The Questionnaire of Olfactory Disorders (QOD) is a self-report instrument assessing the subjective impact of olfactory dysfunction on quality of life and daily functioning. Derived from olfactory research standardized testing (Sniffin' Sticks) and adapted for clinical use, the QOD measures perceived smell loss, changes in taste (retronasal olfaction), and emotional consequences of anosmia or hyposmia. It is increasingly used in otolaryngology, post-viral olfactory loss assessment, and chronic rhinosinusitis programs to quantify disease burden and monitor treatment response. | The Nasal Obstruction Symptom Evaluation (NOSE) Scale is a brief 5-item self-report questionnaire specifically designed to measure the severity of nasal obstruction and its impact on quality of life. Developed by Stewart and colleagues (2004), the NOSE is the most widely used nasal obstruction-specific outcome measure in otolaryngology, recommended for clinical practice and clinical trials. It is validated for baseline assessment, monitoring treatment response in medical and surgical rhinology, and outcome evaluation following septoplasty, rhinoplasty, endoscopic sinus surgery, or allergen immunotherapy. |
| ScholarGateDatu kopa ↗ |
|
|